STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

DRAVET SYNDROME FOUNDATION INC: Form 990, tax year 2025

View the entire original 990 at ProPublica ↗

Organization
DRAVET SYNDROME FOUNDATION INC (EIN 27-0924627)
Tax period
2025-01-01 to 2025-12-31
Filed
2026-04-29
IRS object ID
202631199349301853
Schema version
2025v4.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2026-04-29T10:17:36-07:00ReturnTs
Tax Period End2025-12-31TaxPeriodEndDt
Return Type990ReturnTypeCd
Tax Period Begin2025-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN270924627EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1DRAVET SYNDROME FOUNDATION INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlDRAVBusinessNameControlTxt
Phone2033921955PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO Box 3026AddressLine1Txt
CityCherry HillCityNm
State AbbreviationNJStateAbbreviationCd
ZIP08034ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonRoss NicholasPersonNm
Person TitleBoard ChairPersonTitleTxt
Phone2033921955PhoneNum
Signature2026-04-27SignatureDt
FieldValueIRS element (for citing)
Tax2025TaxYr
Build TS2025-03-06 01:10:19ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerMary Anne MeskisPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO Box 3026AddressLine1Txt
CityCherry HillCityNm
State AbbreviationNJStateAbbreviationCd
ZIP08002ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$5,169,419GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.dravetfoundation.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2009FormationYr
Legal Domicile StateCTLegalDomicileStateCd
Activity Or MissionThe mission of the Dravet Syndrome Foundation is to aggressively raise funds for Dravet syndrome & related epilepsies; support & fund research; increase awareness; & provide support to affected individuals & families.ActivityOrMissionDesc
Voting Members Governing Body8VotingMembersGoverningBodyCnt
Voting Members Independent8VotingMembersIndependentCnt
Total Employee13TotalEmployeeCnt
Total Volunteers100TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$3,106,931PYContributionsGrantsAmt
CY Contributions Grants$3,831,992CYContributionsGrantsAmt
PY Program Service Revenue$734,789PYProgramServiceRevenueAmt
CY Program Service Revenue$600,050CYProgramServiceRevenueAmt
PY Investment Income$304,376PYInvestmentIncomeAmt
CY Investment Income$273,034CYInvestmentIncomeAmt
PY Other Revenue$75,526PYOtherRevenueAmt
CY Other Revenue$47,167CYOtherRevenueAmt
PY Total Revenue$4,221,622PYTotalRevenueAmt
CY Total Revenue$4,752,243CYTotalRevenueAmt
PY Grants And Similar Paid$2,509,120PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$3,290,753CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$841,275PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$909,231CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$231,048CYTotalFundraisingExpenseAmt
PY Other Expenses$908,777PYOtherExpensesAmt
CY Other Expenses$583,681CYOtherExpensesAmt
PY Total Expenses$4,259,172PYTotalExpensesAmt
CY Total Expenses$4,783,665CYTotalExpensesAmt
PY Revenues Less Expenses-$37,550PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$31,422CYRevenuesLessExpensesAmt
Total Assets BOY$8,536,916TotalAssetsBOYAmt
Total Assets EOY$9,833,611TotalAssetsEOYAmt
Total Liabilities BOY$1,510,060TotalLiabilitiesBOYAmt
Total Liabilities EOY$2,652,358TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$7,026,856NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$7,181,253NetAssetsOrFundBalancesEOYAmt
MissionThe mission of the Dravet Syndrome Foundation is to aggressively raise funds for Dravet syndrome & related epilepsies; support & fund research; increase awareness; & provide support to affected individuals & families. We understand the ongoing need to fund innovative research, the urgency in finding better treatments, the motivation of our donors to make an impact specifically in the fields of Dravet syndrome and related epilepsies, the importance of transparency and accountability of not only our organization, but the researchers that we fund, and the need for global collaboration in order to find a cure.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$3,444,887ExpenseAmt
Grant$3,262,635GrantAmt
Revenue$0RevenueAmt
DescDSF funds research for better treatments and a cure for Dravet syndrome and related epilepsies by awarding research grants to qualified scientists and clinicians. These grants fund initial research hypotheses that have not been fully explored. The results extracted from this type of research will help bring untested research to the point that it can qualify for larger governmental funding. Since 2009, DSF has awarded over $14.1 million to 84 research endeavors. Research areas include SUDEP, gene therapy, drug discovery, screening, treatments, genetics, epidemiology and neuronal networks. DSF has also supported the development of a commercial line of iPSC cells for researchers and the biotechnology industry. DSF's Chief Scientific Officer serves as the liaison between the medical/scientific community and DSF, developing strategies to support research, manage DSF's involvement in projects, and move projects forward with assistance in project management, manuscript preparation, and other writing opportunities. The Chief Scientific Director acts as a representative of DSF to other institutions including NIH, FDA, pharma and biotechnology companies.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$459,959ExpenseAmt
Grant$28,118GrantAmt
Revenue$414,125RevenueAmt
DescReceiving a diagnosis of Dravet syndrome (DS) can be overwhelming, leaving families with many unanswered questions. To support our patient community, DSF provides a variety of educational, advocacy, and support resources: These initiatives are part of DSF's commitment to providing vital resources and fostering a strong, supportive community for those affected by Dravet syndrome. DSF Family Network: Open to any parent, legal guardian, or sibling interested in our advocacy services and programs, the Family Network keeps members informed about new advocacy tools, clinical trials, educational opportunities, and fundraising events. It also includes moderated private Facebook support groups for parents and caregivers of individuals with Dravet syndrome. Membership is limited to those legally responsible for making medical decisions for the patient. In 2025, 280 people joined the Family Network. Newly Diagnosed Kits: DSF provides newly diagnosed families with a kit that includes a guidebook for navigating life after diagnosis, a medication bag, and other materials to ensure they have the knowledge and tools needed for their child's care. In 2025, DSF distributed 115 kits. Patient Assistance Grants: The DSF Patient Assistance Grant Program offers financial support to patients with Dravet syndrome and related SCN1A epilepsies for medical equipment, therapy devices, and educational aids not covered by private insurance or other programs. This program is available to all patients worldwide who are members of the DSF Family Network. Since 2009, DSF has awarded $306,000 to 265 families. Birthday Buddies: Families can register their loved one with Dravet syndrome to receive a birthday card and small gift from DSF's mascot, Aurora, around their birthday. In 2025, DSF sent 677 gifts. Super Siblings Club: DSF provides a day camp at our biennial conference and annual Day of Dravet workshops for siblings of individuals with Dravet syndrome. These events offer a fun and supportive environment for siblings to connect, express their feelings, and bond with others facing similar challenges. Bereavement Support: Losing a loved one, especially a child, is profoundly painful. DSF offers resources for coping with grief, including a Bereavement Support Group and Remembrance Wall. Legislative Advocacy Program: We are committed to keeping our patient community informed about legislative actions affecting Medicaid and rare disease research, which are essential for maintaining access to care and driving advancements in treatment for Dravet syndrome. By ensuring our constituents have accurate and nonpartisan information, they can advocate for their loved one and family effectively. Biennial Conference: This 3-day event brings together families, caregivers, clinicians, researchers, and pharmaceutical professionals to collaborate on improving the lives of those with Dravet syndrome. The conference features presentations on the latest research and patient care, fostering new relationships and collaborations. Over 500 people attended the 2024 conference. Day of Dravet Workshops: Held in alternating years from the biennial conference, these workshops offer families the opportunity to learn about research, treatment options, and connect with others. Sessions are led by community experts, including fellow parents. The workshops also include our VIP Sib Camp and activities for patients. In 2025, 470 attendees, representing 123 families participated at workshops in Texas (San Antonio), Tennessee (Sevierville), Washington (Tacoma), Illinois (Gurnee), and Pennsylvania (Hershey).Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$168,401ExpenseAmt
Grant$0GrantAmt
Revenue$185,925RevenueAmt
DescDSF produces an annual research roundtable meeting to provide opportunity for researchers and clinicians to collaborate and discuss better treatment options and a roadmap toward a cure and how to best facilitate both. This meeting started in 2010 as a brainstorming session for the few researchers working on Dravet syndrome. DSF hosted its 16th annual Research Roundtable with nearly 190 participants.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$0TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$0TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$0TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$4,073,247TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (1)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To IndividualsYes (1)GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org MemYes (1)BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document14IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee13EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members8GoverningBodyVotingMembersCnt
Independent Voting Member8IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org DocumentsYes (1)ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonJamie CohenPersonNm
Phone2033921955PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1522 Mackin DriveAddressLine1Txt
CityCherry HillCityNm
State AbbreviationNJStateAbbreviationCd
ZIP08002ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (13 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndIndividual Trustee Or DirectorIndividualTrusteeOrDirectorInd
Mary Anne Meskis
Chief Executive Officer400Yes (X)$179,356$0$7,165
Veronica Hood PhD
Chief Scientific Officer400$174,406$0$6,967Yes (X)
Jamie Cohen CPA
Chief Financial Officer400Yes (X)$114,984$0$4,590
Ross Nicholas
Chair10Yes (X)$0$0$0Yes (X)
Gail Farfel PhD
Vice Chair10Yes (X)$0$0$0Yes (X)
Claire Carey
Secretary10Yes (X)$0$0$0Yes (X)
Josh Goldman
Treasurer10Yes (X)$0$0$0Yes (X)
Nathan Batt
Director10Yes (X)$0$0$0Yes (X)
Bill Kirshner MD
Director10$0$0$0Yes (X)
Amanda Prather PA-C
Director10$0$0$0Yes (X)
Mike Chieco
Director10$0$0$0Yes (X)
Ted Odlaug PhD
Director10Yes (X)$0$0$0Yes (X)
Joseph Sullivan MD
Director10$0$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$468,746TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$18,722TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K3IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp

Contractor Name ContractorName

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Geben CommunicationBusinessNameLine1Txt

Contractor Address ContractorAddress

US Address USAddress

FieldValueIRS element (for citing)
Address Line1143 E Main St 200AddressLine1Txt
CityColumbusCityNm
State AbbreviationOHStateAbbreviationCd
ZIP43215ZIPCd
FieldValueIRS element (for citing)
ServicesMedia RelationsServicesDesc
Compensation$150,000CompensationAmt
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K1CntrctRcvdGreaterThan100KCnt
Federated Campaigns$0FederatedCampaignsAmt
Membership Dues$0MembershipDuesAmt
Fundraising$1,977,729FundraisingAmt
Related Organizations$0RelatedOrganizationsAmt
Government Grants$0GovernmentGrantsAmt
All Other Contributions$1,854,263AllOtherContributionsAmt
Noncash Contributions$0NoncashContributionsAmt
Total Contributions$3,831,992TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmtExclusionExclusionAmt
Professional Education & Meetings813319$185,925$185,925$0$0
Patient & Family Services813319$414,125$414,125$0$0

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$600,050TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$273,034TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$273,034ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$0SecuritiesAmt
Other$0OtherAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$464,343FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$1,977,729ContriRptFundraisingEventAmt
Fundraising Direct Expenses$417,176FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$47,167TotalRevenueColumnAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$47,167ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$0OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$4,752,243TotalRevenueColumnAmt
Related Or Exempt Func Income$600,050RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$320,201ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$2,777,635TotalAmt
Program Services$2,777,635ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$25,786TotalAmt
Program Services$25,786ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$487,332TotalAmt
Program Services$487,332ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$499,858TotalAmt
Program Services$223,055ProgramServicesAmt
Management And General$270,399ManagementAndGeneralAmt
Fundraising$6,404FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$325,844TotalAmt
Program Services$138,112ProgramServicesAmt
Management And General$37,312ManagementAndGeneralAmt
Fundraising$150,420FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$10,820TotalAmt
Program Services$5,544ProgramServicesAmt
Management And General$133ManagementAndGeneralAmt
Fundraising$5,143FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$6,889TotalAmt
Program Services$3,600ProgramServicesAmt
Management And General$566ManagementAndGeneralAmt
Fundraising$2,723FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$65,820TotalAmt
Program Services$28,580ProgramServicesAmt
Management And General$24,096ManagementAndGeneralAmt
Fundraising$13,144FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$11,500TotalAmt
Management And General$11,500ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$156,594TotalAmt
Program Services$120,400ProgramServicesAmt
Management And General$36,194ManagementAndGeneralAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$184TotalAmt
Management And General$184ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$65,777TotalAmt
Program Services$18,280ProgramServicesAmt
Management And General$26,376ManagementAndGeneralAmt
Fundraising$21,121FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$32,847TotalAmt
Program Services$6,699ProgramServicesAmt
Management And General$23,465ManagementAndGeneralAmt
Fundraising$2,683FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$4,284TotalAmt
Program Services$1,428ProgramServicesAmt
Management And General$1,428ManagementAndGeneralAmt
Fundraising$1,428FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$60,237TotalAmt
Program Services$44,990ProgramServicesAmt
Management And General$10,462ManagementAndGeneralAmt
Fundraising$4,785FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$196,170TotalAmt
Program Services$187,064ProgramServicesAmt
Management And General$5,388ManagementAndGeneralAmt
Fundraising$3,718FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$2,951TotalAmt
Management And General$2,951ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$6,093TotalAmt
Program Services$777ProgramServicesAmt
Management And General$4,905ManagementAndGeneralAmt
Fundraising$411FundraisingAmt

Other Expenses OtherExpensesGrp (2 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
Charity Registration Fees$4,446$0$4,446$0
Dues & Subscriptions$42,598$3,965$19,565$19,068

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$4,783,665TotalAmt
Program Services$4,073,247ProgramServicesAmt
Management And General$479,370ManagementAndGeneralAmt
Fundraising$231,048FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$383,617BOYAmt
EOY$420,091EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$1,696,246BOYAmt
EOY$1,545,160EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$36,352BOYAmt
EOY$175,474EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$19,025BOYAmt
EOY$45,214EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$56,059BOYAmt
EOY$129,081EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$11,435LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$2,951LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
EOY$8,484EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$6,345,617BOYAmt
EOY$7,510,107EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$8,536,916BOYAmt
EOY$9,833,611EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$50,233BOYAmt
EOY$110,097EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$1,442,946BOYAmt
EOY$2,520,965EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$16,881BOYAmt
EOY$21,296EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,510,060BOYAmt
EOY$2,652,358EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$6,988,189BOYAmt
EOY$6,761,560EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$38,667BOYAmt
EOY$419,693EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$7,026,856BOYAmt
EOY$7,181,253EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$8,536,916BOYAmt
EOY$9,833,611EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$31,422ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$143,239NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts$0DonatedServicesAndUseFcltsAmt
Investment Expense$0InvestmentExpenseAmt
Prior Period Adjustments$0PriorPeriodAdjustmentsAmt
Other Changes In Net Assets$42,580OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,437,446CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,713,227CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$2,530,132CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$3,106,930CurrentTaxYearMinus1YearAmt
Current Tax Year$3,831,992CurrentTaxYearAmt
Total$12,619,727TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,437,446CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,713,227CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$2,530,132CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$3,106,930CurrentTaxYearMinus1YearAmt
Current Tax Year$3,831,992CurrentTaxYearAmt
Total$12,619,727TotalAmt
FieldValueIRS element (for citing)
Public Support Total170$12,619,727PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,151CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$88,364CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$218,415CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$304,376CurrentTaxYearMinus1YearAmt
Current Tax Year$273,034CurrentTaxYearAmt
Total$889,340TotalAmt
FieldValueIRS element (for citing)
Total Support$13,509,067TotalSupportAmt
Public Support CY1700.93417PublicSupportCY170Pct
Public Support PY1700.94060PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,682FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$2,099FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$3,781FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$4,779,885FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$4,783,666FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$389,183FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$97,296FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$0CurrentYearMinus3Amt
Current Year Minus2$0CurrentYearMinus2Amt
Current Year Minus1$362,959CurrentYearMinus1Amt
Current Year$389,183CurrentYearAmt
Total$752,142TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$1,128,213LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$0CurrentYearMinus3Amt
Current Year Minus2$0CurrentYearMinus2Amt
Current Year Minus1$9,282CurrentYearMinus1Amt
Current Year$3,781CurrentYearAmt
Total$13,063TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$0CurrentYearMinus3Amt
Current Year Minus2$0CurrentYearMinus2Amt
Current Year Minus1$90,740CurrentYearMinus1Amt
Current Year$97,296CurrentYearAmt
Total$188,036TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$282,054GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$0CurrentYearMinus3Amt
Current Year Minus2$0CurrentYearMinus2Amt
Current Year Minus1$2,984CurrentYearMinus1Amt
Current Year$1,682CurrentYearAmt
Total$4,666TotalAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$937,673BeginningYearBalanceAmt
Contributions$360,009ContributionsAmt
Investment Earnings Or Losses$170,628InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$0OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$1,468,310EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$549,579BeginningYearBalanceAmt
Contributions$271,071ContributionsAmt
Investment Earnings Or Losses$117,023InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$0OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$937,673EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$228,680BeginningYearBalanceAmt
Contributions$250,000ContributionsAmt
Investment Earnings Or Losses$70,899InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$0OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$549,579EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$275,171BeginningYearBalanceAmt
Contributions$0ContributionsAmt
Investment Earnings Or Losses-$46,491InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$0OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$228,680EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$101,887BeginningYearBalanceAmt
Contributions$150,000ContributionsAmt
Investment Earnings Or Losses$23,285InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$0OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$275,172EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.9993BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.0007PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org0EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org0EndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Book Value$0BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Depreciation$0DepreciationAmt
Book Value$0BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Depreciation$0DepreciationAmt
Book Value$0BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$11,435OtherCostOrOtherBasisAmt
Depreciation$2,951DepreciationAmt
Book Value$8,484BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Depreciation$0DepreciationAmt
Book Value$0BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$8,484TotalBookValueLandBuildingsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt
Total Liability$0TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$4,895,482TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$143,239NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$0DonatedServicesAndUseFcltsAmt
Recoveries Prior Year Grants$0RecoveriesPriorYearGrantsAmt
Other Revenue$0OtherRevenueAmt
Revenue Not Reported$143,239RevenueNotReportedAmt
Revenue Subtotal$4,752,243RevenueSubtotalAmt
Investment Expenses Not Incld$0InvestmentExpensesNotIncldAmt
Other Revenues Not Included$0OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$4,752,243TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$4,741,085TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$0DonatedServicesUseFcltsAmt
Prior Year Adjustments$0PriorYearAdjustmentsAmt
Losses Reported$0LossesReportedAmt
Other Expenses Included$0OtherExpensesIncludedAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$4,741,085ExpensesSubtotalAmt
Investment Expenses Not Incld2$0InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$42,580OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$42,580ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$4,783,665TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule D, Part V, Line 4The purpose of the Endowment is to support the mission of the Foundation by providing an alternative source of funds for current and future use. The endowment has two primary goals. First, the principal of the endowment's assets which are not self-funded, must be preserved in perpetuity; second, the endowment should strive to achieve investment returns sufficient to supplement ongoing Foundation operations. To the extent these first two goals are achieved, the Foundation endeavors to grow the endowment so that it represents an even larger source of funding for future generations.
Schedule D, Part X, Line 2DSF recognizes the effect of tax positions only when they are more than likely than not of being sustained. Management has determined that DSF had no uncertain tax positions that qualify for either recognition or disclosure in the financial statements. In the normal course of business DSF's tax filings are subjected to examination by federal and state authorities. The tax returns for the years ended December 31, 2022 and forward are subject to examination by taxing authorities.
Schedule D, Part XII, Line 4bPresent value discount on grant payable not recognized on Form 990.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
Europe (including Iceland and Greenland)00Grantmaking$355,000
Middle East and North Africa00Grantmaking$130,000
North America (including Canada and Mexico, but not the United States)00Grantmaking$2,332
FieldValueIRS element (for citing)
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Total Spent$487,332TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (2 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxtNon Cash AssistanceNonCashAssistanceAmtValuation Method UsedValuationMethodUsedDesc
Europe (including Iceland and Greenland)1. Leiden University Medical Center - Research Grant: Neurophysiological Characterization of the Therapeutic Effect of Exogenous Nav1.1 Channels - $110,000. 2.Royal College of Surgeons Ireland - Postdoctoral Fellowship: Multi-Target Strategy for Dravet Syndrome: Enhancing Sodium Channels and GABA Receptors via miRNA Inhibition - $75,000. 3. Institut de Génétique Moléculaire de Montpellier, in conjunction with Tel Aviv University and The Children's Hospital of Philadelphia - Transformational Science Grant: Molecular Characterization of the Therapeutic Effect of Exogenous Nav1.1 - $170,000. Details for each of these projects can be found at https://dravetfoundation.org/dsf-funded-research/$355,000Wire Transfer$0FMV
Middle East and North AfricaTel Aviv University in conjunction with Institut de Génétique Moléculaire de Montpellier and The Children's Hospital of Philadelphia - Transformational Science Grant: Molecular Characterization of the Therapeutic Effect of Exogenous Nav1.1. This study investigates how introducing functional Nav1.1 sodium channels affects cellular and molecular processes. The goal is to better understand how restoring this protein alters neuronal signaling, protein interactions, and downstream pathways. By mapping these effects, researchers aim to identify mechanisms of therapeutic benefit and potential biomarkers of response. Insights from this work will guide optimization of Nav1.1-based therapies and support the development of more targeted and effective treatment strategies.$130,000Wire Transfer$0FMV
FieldValueIRS element (for citing)
Total501c3 Org3Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule F, Part I, Line 2FormAndLineReferenceDesc
ExplanationDSF provides funds for research. The organizations receiving this assistance are required to provide written progress reports on their research into finding a cure for Dravet syndrome and related epilepsies. The Chief Scientific Officer of DSF reviews the written progress reports and discusses the research projects and progress with the awarded organization. DSF also provides funding to patients with Dravet syndrome and related epilepsies for necessary medical equipment, therapy devices and education aids associated with these conditions that are not covered through private insurance or other assistance programs. Applicants are required to submit an application that includes a recent letter from the child's healthcare provider explaining the medical necessity of the request and when possible, a letter of denial from the insurance provider.ExplanationTxt

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1Dance for DravetEvent1Nm
Gross Receipts Event1$889,679GrossReceiptsEvent1Amt
Charitable Contri Event1$699,303CharitableContriEvent1Amt
Gross Revenue Event1$190,376GrossRevenueEvent1Amt
Cash Prizes Event1$0CashPrizesEvent1Amt
Non Cash Prizes Event1$0NonCashPrizesEvent1Amt
Rent Facility Costs Event1$14,297RentFacilityCostsEvent1Amt
Food And Beverage Event1$77,846FoodAndBeverageEvent1Amt
Entertainment Event1$7,262EntertainmentEvent1Amt
Other Direct Expenses Event1$30,866OtherDirectExpensesEvent1Amt
Event2City Bash: Rally for DravetEvent2Nm
Gross Receipts Event2$489,973GrossReceiptsEvent2Amt
Charitable Contri Event2$437,161CharitableContriEvent2Amt
Gross Revenue Event2$52,812GrossRevenueEvent2Amt
Cash Prizes Event2$0CashPrizesEvent2Amt
Non Cash Prizes Event2$0NonCashPrizesEvent2Amt
Rent Facility Costs Event2$30,310RentFacilityCostsEvent2Amt
Food And Beverage Event2$26,844FoodAndBeverageEvent2Amt
Entertainment Event2$1,925EntertainmentEvent2Amt
Other Direct Expenses Event2$30,309OtherDirectExpensesEvent2Amt
Other Events Total19OtherEventsTotalCnt
Gross Receipts Other Events$1,062,420GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$841,264CharitableContriOtherEventsAmt
Gross Revenue Other Events$221,156GrossRevenueOtherEventsAmt
Cash Prizes Other Events$0CashPrizesOtherEventsAmt
Non Cash Prizes Other Events$0NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events$29,242RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$73,519FoodAndBeverageOtherEventsAmt
Entertainment Other Events$17,325EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events$77,430OthDirectExpnssOtherEventsAmt
Gross Receipts Total$2,442,072GrossReceiptsTotalAmt
Charitable Contributions Tot$1,977,728CharitableContributionsTotAmt
Gross Revenue Total Events$464,344GrossRevenueTotalEventsAmt
Cash Prizes Total Events$0CashPrizesTotalEventsAmt
Non Cash Prizes Total Events$0NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events$73,849RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$178,209FoodAndBeverageTotalEventsAmt
Entertainment Total Events$26,512EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$138,605OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$417,175DirectExpenseSummaryEventsAmt
Net Income Summary$47,169NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (9 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtValuation Method UsedValuationMethodUsedDescPurpose Of GrantPurposeOfGrantTxt
Regents of the University of Michigan
3003 South State StreetAnn ArborMI48109386006309501(c)(3)$779,250$0FMV1. University of Michigan - Special Project Funding:Understanding Phenotypes and Biomarkers Leading to SUDEP in a Transgenic Rabbit Model - $750,000. This study uses a transgenic rabbit model of Dravet syndrome to identify observable traits and measurable biomarkers associated with increased risk of sudden unexpected death in epilepsy (SUDEP). The goal is to characterize physiological, behavioral, and cardiac indicators that precede critical events. By establishing reliable biomarkers, the research aims to improve risk stratification and enable earlier intervention. The model also provides a platform for testing preventative strategies and understanding underlying mechanisms. 2. In conjunction with Stanford University - Special Project Funding: Identification of Behavioral Biomarkers in Children with DS: A Pilot Study - $29,250. Details for each of these projects can be found at https://dravetfoundation.org/dsf-funded-research/
Regents of the University of Colorado
1800 N Grant St Ste 200DenverCO80203846000555501(c)(3)$662,231$0FMVDravet Syndrome Natural History Study. The Natural History study will recruit and follow children and adults with Dravet Syndrome to track how often and how severely issues like behavior, development, sleep, appetite, autonomic symptoms, and motor function occur and change over time. The study will establish a robust database that will capture standardized clinical, neuropsychological, and parent-reported data on key signs and symptoms across the lifetime. The study will also explore how these outcomes connect to specific genetic changes to better understand how different types of mutations might influence Dravet Syndrome. This study will increase understanding of Dravet syndrome, and lead to better design of treatments and clinical trials.
Allen Institute
615 Westlake Ave NSeattleWA98109912155317501(c)(3)$449,785$0FMVCircuit-Selective Whole SCN1A Gene Delivery for Dravet Syndrome. This research focuses on delivering a full-length functional gene specifically to affected neural circuits rather than broadly across the brain utilizing different mouse models of Dravet syndrome. The goal is to improve therapeutic precision while minimizing off-target effects. Using advanced vector systems and targeting strategies, the team aims to restore gene function in key cell populations responsible for disease symptoms. This approach seeks to enhance efficacy and safety of gene therapy by tailoring delivery to the most relevant neural networks.
The Board of Trustees of the Leland Stanford Junior University
450 Jane Stanford WayStanfordCA943052004941156365501(c)(3)$309,500$0FMVIdentification of Behavioral Biomarkers in Children with DS: A Pilot Study In conjunction with University of Michigan, this pilot study seeks utilize AI and machine learning to identify subtle but measurable behavioral patterns that can serve as biomarkers for disease progression and treatment response in Dravet syndrome that would be undetectable using traditional observational methods. Researchers aim to define objective indicators of cognitive, social, and functional changes with the goal to improve clinical trial endpoints and enable more sensitive tracking of outcomes. Findings may support the development of better tools for evaluating therapeutic impact in patient populations.
Children's Hospital of Pennsylvania
2716 South StreetPhiladelphiaPA191462305231352166501(c)(3)$240,000$0FMV1. In conjunction with Tel Aviv University and Institut de Génétique Moléculaire de Montpellier - Transformational Science Grant: Molecular Characterization of the Therapeutic Effect of Exogenous Nav1.1 - $150,000. 2. In conjunction with MIT and Harvard University - Research Grant: Base Editing for the Treatment and Prevention of Dravet Syndrome - $90,000. Details for each of these projects can be found at https://dravetfoundation.org/dsf-funded-research/
The Broad Institute of MIT and Harvard
415 Main StreetCambridgeMA02142263428781501(c)(3)$100,000$0FMVIn conjunction with The Children's Hospital of Philadelphia, Base Editing for the Treatment and Prevention of Dravet Syndrome. This project aims to develop a precision gene-editing approach using base editing technology to directly correct disease-causing mutations at the DNA level using a mouse model of Dravet syndrome. The goal is to create a durable, potentially one-time treatment that can restore normal gene function without introducing double-strand DNA breaks. Researchers are working to optimize delivery systems, improve editing efficiency, and evaluate safety in relevant models. Ultimately, the project seeks to establish a foundation for preventive or early-intervention therapies that address the root genetic cause rather than managing symptoms.
The Research Foundation for the State University of New York
35 State StreetAlbanyNY12207141368361501(c)(3)$100,000$0FMVAward Supplement for Genetic Substrates and Physiological Triggers for Autonomic and Cardiac Abnormalities. This project investigates the genetic and physiological factors underlying autonomic and cardiac dysfunction in Dravet syndrome and closely related epilepsy disorders. The goal is to identify specific triggers and biological mechanisms that contribute to irregular heart rhythms and autonomic instability. Researchers are integrating genetic analysis with physiological monitoring to better understand risk factors. Insights from this work may inform strategies to predict, monitor, and reduce life-threatening complications for Dravet syndrome.
The Children's Hospital Corporation dba Boston Children's Hospital
300 Longwood AvenueBostonMA02115042774441501(c)(3)$77,500$0FMVSelective Activation of Hippocampal Parvalbumin Interneurons via Focused Ultrasound Neuromodulation for Seizure Suppression in SCN1A Mice. This project evaluates a non-invasive neuromodulation approach using focused ultrasound to selectively activate specific inhibitory neurons in the brain. By targeting parvalbumin interneurons in the hippocampus, researchers aim to reduce hyperexcitability and suppress seizures in Dravet syndrome. The study assesses feasibility, precision, and effectiveness in preclinical models, while also examining safety and durability of the response. The long-term goal is to develop a targeted, non-pharmacological intervention for seizure control.
Coriell Institute for Medical Research
403 Haddon AveCamdenNJ08103210672684501(c)(3)$9,369$0FMVCreating a biobank of patient-derived induced pluripotent stem cells. This project aims to establish a biobank of five unique lines of commercially-available induced pluripotent stem cells (iPSCs) from patient blood samples. The cellular reprogramming will be conducted by the Coriell Institute for Medical Research and samples will be housed and distributed through an additional partnership with the Orphan Disease Center at The University of Pennsylvania. Cell lines will be available to researchers in academic and for-profit research settings at a low cost, set to cover the long-term maintenance of the biobank effort.
FieldValueIRS element (for citing)
Total501c3 Org9Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)

Grant TypeGrantTypeTxtRecipientRecipientCntCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtValuation Method UsedValuationMethodUsedDescNon Cash AssistanceNonCashAssistanceDesc
Patient Assistance Grants. DSF supports families living with Dravet syndrome and related epilepsies through several targeted grant programs. Our Patient Assistance Grants help cover the cost of essential medical equipment, therapeutic devices, educational supports, and specialized dietary needs not funded by insurance or other programs, and are available to DSF Family Network members worldwide. Additionally, in the U.S., Disaster Relief and Recovery Grants provide $500 Visa or Amazon e-cards to families impacted by significant natural disasters to assist with urgent needs such as housing and food. Bereavement Grants offer $1,000 in flexible support to families who have lost a child, while Caregiver Connect Grants provide up to $500 to support small, regional gatherings that foster connection and peer support.28$2,373$22,613FMVItems that are currently covered under this program include: durable medical goods (such as wheelchairs, orthotics, cooling vests, etc.), therapy equipment, communication devices such as iPads, and costs associated with implementation of the ketogenic diet. By awarding these grants, DSF is making no recommendation to the appropriateness or safety of a particular piece of equipment or therapy in treating Dravet syndrome and associated epilepsies and conditions. DSF and its Board of Directors are not responsible for the safety and use of awarded equipment or therapies. Applicants are strongly urged to consult with their medical professionals and therapists regarding equipment and therapies that would be most beneficial for the situation.
Caregiver Connect Grants. Caregiver Connect Grants are available from $100-$400 and can partially or fully fund a local Dravet family gathering or an ongoing Dravet support group in your area. The goal of the grants is to allow our community members to connect and receive support from one another. At this time, Caregiver Connect grants are only available for events within the United States that are members of the DSF Family Network. Funds are not available for parties for an individual child or family, awareness events, or for the benefit of individuals outside of the Dravet community.2$800$0FMV

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule I, Part I, Line 2FormAndLineReferenceDesc
ExplanationDSF provides funds for research. The organizations receiving this assistance are required to provide written progress reports on their research into finding a cure for Dravet syndrome and related epilepsies. The Chief Scientific Officer of DSF reviews the written progress reports and discusses the research projects and progress with the awarded organization. DSF is committed to supporting families in meaningful and practical ways through a range of patient community-focused grant programs. These include: Patient Assistance Grants, which help cover the cost of essential medical and therapeutic equipment. Disaster Relief Grants, designed to provide immediate assistance to families impacted by natural disasters during times of unexpected hardship. Caregiver Connect Grants, which fund opportunities for families to come together regionally, fostering connection, shared experiences, and peer support. Bereavement Grants, offering compassionate support to families who have experienced the loss of a child.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (2 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Mary Anne Meskis
Chief Executive Officer$178,156$0$0$0$1,200$0$7,165$0$0$0$186,521$0$0$0
Veronica Hood PhD
Chief Scientific Officer$173,206$0$0$0$1,200$0$6,967$0$0$0$181,373$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule J, Part IIFormAndLineReferenceDesc
ExplanationCompensation reported in Part VII and Schedule J reflects calendar-year Form W-2 reportable compensation. The organization accrued a bonus of $4,458 to Mary Anne Meskis and $4,182 to Veronica Hood for 2025 that was paid in 2026 and will be reported on the employee's 2026 Form W-2. Accordingly, the bonus is included in 2025 compensation expense in Part IX but not in Part VII or Schedule J for 2025.ExplanationTxt

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (2 entries)

Relationship DescriptionRelationshipDescriptionTxtTransactionTransactionAmtTransactionTransactionDescSharing Of RevenuesSharingOfRevenuesInd
Substantial Contributor
Board Trustee of Organization$150,000Contribution0
Substantial Contributor
Board Trustee of Organization$558,679Contribution0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule L, Part IVFormAndLineReferenceDesc
ExplanationTwo board members also serve on two other 501(c)(3) organizations dedicated to advancing research for Dravet syndrome. Rather than reviewing grant applications through their organizations, they prefer to support grants that our Scientific and Medical Advisory Boards have vetted and approved each year, ensuring that these projects receive the necessary resources to make a meaningful impact in the field.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Form 990, Part VI, Section A, Line 4The bylaws were amended on 09/24/2025 to update Article II, Section 2.2 to change the maximum number of voting members of the governing body from 9 to 15.
Form 990, Part VI, Section B, Line 11bA copy of Form 990 and all related schedules is provided to the executive committee of the board of directors for review prior to filing with the Internal Revenue Service.
Form 990, Part VI, Section B, Line 12cA conflict of interest disclosures statement is distributed and signed by each board member annually. Conflicts are dealt with on a case-by-case basis.
Form 990, Part VI, Section B, Line 15In 2025, the DSF Board of Directors established a Compensation Committee whose purpose is to ensure the Foundation's Board of Directors determines the adequacy and reasonableness of the total compensation paid to the Chief Executive Officer and compensation ranges for other senior leadership team members. The committee is responsible for 1.Conducting an annual review of the CEO's performance and total compensation in relation to the marketplace; soliciting board input regarding the CEO's performance against annual performance goals; decide on any changes in the CEO's total compensation; decided on any changes in the CEO's employment agreement, severance, and/or retention agreement, if any are in effect. 2. With respect to Senior Leadership (including the CEO), a compensation market analysis by a neutral third party consultant will be conducted every two years to gather and review in advance appropriate market comparability data on the amount and form of compensation paid for comparable executive positions by other comparable employers, including those organizations with which the Foundation may be competing for executive talent, and to assure that the comparability data gathered and reviewed meets the standard for "Appropriate Data as to Comparability" to qualify for the rebuttable presumption of reasonableness under Internal Revenue Code Section 4958. 3. Before the Board of Directors next meeting or within sixty (60) days after making its determination of reasonableness with respect to the total compensation of all team members (including the CEO) will document in a written report: (A) The terms that were approved and the date approved; (B) The members of the Compensation Committee present during the discussion and those who voted in favor and those who dissented or abstained; (C) The comparability data obtained and relied upon by the Compensation Committee and how the data was obtained; and (D) Any actions taken with respect to the determination by anyone who is otherwise a member of the committee but who had a conflict of interest. The report must be approved by the Compensation Committee as reasonably accurate and complete within a reasonable time thereafter and reported to the Board of Directors. The process described here was last completed in 2025.
Form 990, Part VI, Section C, Line 19DSF makes its governing documents and conflict of interest policy available to the public upon written request from the president. Financial statements are available for public view on the organization's website.
Form 990, Part XI, Line 9The organization recorded adjustments of $50,803 for the prior year and $42,582 for the current year to reflect changes in the net present value of long-term grants payable. These adjustments represent the periodic remeasurement of the liability, capturing the effects of the passage of time and any updates to the discount rate, in accordance with generally accepted accounting principles (GAAP).